Benign neoplasm: Epididymis

CD2_BENIGN_EPIDIDYMIS

testicular carcinoma: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D29.3& Hospital discharge: ICD-9 — 2223 Cause of death: ICD-10 — D29.3& Cause of death: ICD-9 — 2223 2 out of 7 registries used, show all original rules.	113
4. Check minimum number of events None	113
5. Include endpoints None	113
6. Filter based on genotype QC (FinnGen only)	113

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D29
Name in latin: Neoplasma benignum epididymidis

NAME	CD2_BENIGN_EPIDIDYMIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D293
HD_ICD_9	2223
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D293
COD_ICD_9	2223
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Epididymis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Epididymis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	908	-	908
Only index persons	837	-	837
Unadjusted period prevalence (%)
Whole population	0.03	-	0.03
Only index persons	0.03	-	0.03
Median age at first event (years)
Whole population	-	-	51.60
Only index persons	-	-	50.67

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	113	-	113
Unadjusted period prevalence (%)	0.05	-	0.05
Median age at first event (years)	53.40	-	53.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
102: Matched controls
1020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D29.3

ICD-10 Finland

Benign neoplasm: Epididymis

+∞

112.2

KFD16

NOMESCO Finland

Partial excision of epididymis

+∞

25.0

2223A

ICD-9 Finland

Benign neoplasm of male genital organs, Epididymis

+∞

17.2

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

12.4

9.2

N43.4

ICD-10 Finland

Spermatocele

10.9

8.7

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

48.9

7.8

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

292

2.12

3.62

1.8

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

401

1.99

3.19

5.2

7.2

1.2

mmol/l

0.00

342

(3002582) Erythrocytes [#/volume] in Urine

287

1.94

2.85

3.5

2.8

38.5

261.7

e6/l

0.50

222

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

726

2.18

2.84

3.3

3.7

1.8

2.0

mu/l

0.75

654

(3042631) Mycobacterium sp identified in Specimen

8.64

2.77

2.2

2.0

—

(3032080) INR in Blood by Coagulation assay

390

1.86

2.68

5.9

8.1

1.2

inr

0.05

108

(3026782) Osmolality of Urine

179

2.01

2.57

3.6

2.7

624.4

609.8

mosm/kgh2o

0.13

153

(3026008) Bacteria identified in Urine by Culture

182

1.97

2.45

2.3

3.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

342

1.76

2.23

3.4

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

573

1.77

2.19

4.1

3.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

102

895

2.43

2.15

13.9

15.2

28.4

26.7

mg/l

0.18

719

(3020564) Creatinine [Moles/volume] in Serum or Plasma

105

949

2.50

2.05

17.1

18.3

90.4

86.9

umol/l

0.72

105

949

(1761482) Bacteria [#/volume] in Urine by Culture

3.11

1.98

3.4

5.3

—

(3018095) Leukocytes [#/volume] in Urine

316

1.70

1.95

4.1

3.2

36.6

108.5

e6/l

0.42

237

(40768443) Skin Pathology biopsy report

2.99

1.90

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

260

1.70

1.79

3.7

2.8

0.5

0.6

e6/l

0.11

196

(3018418) pH of Serum or Plasma

235

1.71

1.76

3.3

4.1

7.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

301

1.63

1.64

1.8

2.0

77.3

89.5

pmol/l

1.10

168

(40761511) CBC panel - Blood by Automated count

102

923

2.08

1.51

14.0

14.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

796

1.74

1.50

14.5

16.3

42.0

41.4

0.31

593

(40768797) Stomach Pathology biopsy report

104

1.87

1.47

1.3

1.4

—

(3022145) Colonoscopy Study observation

1.88

1.37

1.5

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

388

1.52

1.34

3.9

4.3

—

(3002256) Pathology report gross observation

1.82

1.25

1.3

—

(3000330) Specific gravity of Urine by Test strip

2.07

1.14

3.4

4.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

155

1.61

1.12

2.6

2.7

1.0

0.5

e6/l

0.36

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.26

1.10

3.6

2.4

—

(36304419) Bacteria [Presence] in Urine

244

1.50

1.08

4.0

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

100

922

1.74

1.05

18.2

17.9

4.0

mmol/l

0.85

100

905

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

512

1.42

1.02

2.3

2.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.96

0.0

1.6

—

(3049717) Cytology report of Urine Cyto stain

1.95

0.96

5.0

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

918

1.63

0.91

18.3

17.8

139.6

mmol/l

0.10

900

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

289

1.42

0.91

4.5

2.9

62.7

55.6

u/l

0.79

274

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

376

1.38

0.86

4.0

3.9

18.1

51.5

ng/l

2.60

272

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

168

1.46

0.80

2.4

2.5

2.7

0.9

e6/l

0.42

100

(3019225) pH of Specimen

1.67

0.78

2.5

4.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.72

0.77

6.0

6.7

26.3

24.2

mmol/l

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

154

1.45

0.71

1.8

1.9

31.2

29.8

0.31

149

(3041096) Erythrocytes [Presence] in Urine by Automated

227

1.37

0.69

3.4

3.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

182

1.40

0.69

4.0

5.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

856

1.40

0.66

5.0

4.6

6.0

6.2

mmol/l

1.50

788

(3037522) Nuclear Ab [Titer] in Serum

104

0.55

0.65

1.7

1.3

—

292.7

—

(3013512) EKG study

257

1.34

0.65

4.1

4.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.70

0.62

1.0

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

112

0.60

0.62

1.3

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

402

1.29

0.61

7.5

6.7

27.3

25.6

0.47

384

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.58

0.61

2.0

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

661

1.29

0.61

5.2

4.5

1.9

2.4

ug/l

0.48

593

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.61

0.0

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.61

0.0

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

414

1.28

0.58

3.2

3.5

0.0

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

407

1.27

0.55

4.8

0.0

estimate

—

(3000492) Spirometry study

100

0.58

0.54

1.2

1.4

—

(3044889) 12 lead EKG panel

636

1.26

0.54

3.9

4.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.53

0.52

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

382

1.25

0.49

10.7

10.4

0.0

e9/l

0.52

315

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.43

0.46

1.3

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

695

1.24

0.44

7.8

8.2

78.6

79.3

u/l

0.06

666

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.64

0.43

1.2

2.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.64

0.43

1.6

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.43

0.43

1.6

2.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.41

0.0

1.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.41

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.41

0.0

4.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.8

—

3.0

—

(40761536) Microorganisms panel - Urine sediment

1.33

0.40

6.4

3.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.2

—

(3012544) pH of Venous blood

1.37

0.39

2.5

4.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.39

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

146

0.73

0.39

1.6

2.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.38

1.8

2.1

—

(40758558) Short blood count panel - Blood

209

1.25

0.38

7.6

6.6

—

(3003694) ABO and Rh group [Type] in Blood

209

1.25

0.38

1.5

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

835

0.82

0.37

6.9

6.3

40.3

41.5

mmol/mol

0.62

788

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

530

1.19

0.37

4.3

4.1

20.8

21.9

0.20

244

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.63

0.37

1.2

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

869

1.24

0.35

4.1

1.3

1.4

mmol/l

0.38

798

(3022621) pH of Urine by Test strip

1.35

0.34

1.7

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

405

1.18

0.34

3.4

3.5

0.0

estimate

—

(4035726)

1.39

0.33

1.2

1.4

—

(3001604) Monocytes [#/volume] in Blood

426

1.18

0.32

5.7

6.5

0.7

0.6

e9/l

0.32

372

(3006315) Basophils [#/volume] in Blood

428

1.17

0.30

5.8

6.6

0.0

e9/l

0.02

376

(3011397) Hemoglobin [Presence] in Urine by Test strip

193

0.80

0.29

2.8

3.6

—

(40761535) Cells panel - Urine sediment

0.67

0.27

1.4

3.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

159

0.79

0.27

1.2

1.3

0.9

1.2

u/ml

—

(3016502) Oxygen saturation in Arterial blood

105

1.27

0.26

7.2

7.6

96.8

95.7

0.67

100

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

209

1.19

0.25

2.8

2.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

115

1.25

0.25

7.5

7.4

5.0

kpa

0.04

107

(3027801) Oxygen [Partial pressure] in Arterial blood

115

1.25

0.25

7.4

13.3

11.5

kpa

0.53

109

(3023368) Bacteria identified in Blood by Culture

277

1.16

0.25

4.0

5.2

—

(3002032) Base excess in Venous blood by calculation

1.27

0.24

2.3

4.4

3.2

1.6

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.33

0.23

1.4

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

2.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(4268621)

0.00

0.21

0.0

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

13.0

—

1090.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

110

0.80

0.21

1.4

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.26

0.20

11.3

9.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3044941) Cell count panel - Synovial fluid

0.00

0.20

0.0

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

157

1.17

0.19

1.6

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1.14

0.17

4.9

2.7

0.0

2.2

mmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.14

0.17

1.7

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.70

0.17

1.2

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

275

1.12

0.16

2.8

2.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.11

0.15

2.3

2.9

4.3

4.7

kpa

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.11

0.15

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.83

0.14

2.4

3.0

—

(3029937) Albumin [Presence] in Urine by Test strip

220

0.89

0.13

3.9

3.8

0.0

estimate

—

(3000494) Fungus identified in Specimen by Culture

104

1.17

0.13

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

388

1.09

0.12

3.4

2.8

0.7

ug/l

0.22

247

(3009508) Creatinine [Moles/volume] in Urine

290

1.10

0.12

3.6

3.4

8.8

8.6

mmol/l

0.09

246

(3012516) Albumin [Mass/volume] in Urine

272

1.09

0.10

4.0

3.6

30.2

85.1

mg/l

1.85

193

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

842

1.09

0.10

14.1

14.0

78.6

81.9

ml/min/173m2

0.85

711

(3012095) Magnesium [Moles/volume] in Serum or Plasma

165

0.90

0.09

5.5

3.8

0.8

mmol/l

0.16

153

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1.05

0.08

6.7

7.8

24.4

24.1

mmol/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.14

0.08

2.5

4.3

6.1

5.7

kpa

0.92

(3019060) Gas panel - Arterial blood

0.81

0.08

2.8

4.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

295

0.93

0.07

5.9

4.3

4.9

12.8

mg/mmol

1.33

205

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

325

1.07

0.07

3.6

3.8

—

(3000991) Gas panel - Venous blood

1.14

0.07

8.7

7.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

104

0.85

0.06

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

108

0.92

0.03

1.3

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

138

0.93

0.02

2.2

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.08

0.02

6.4

9.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

116

0.94

0.01

1.4

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

274

1.03

0.00

1.6

2.4

73.0

71.8

nmol/l

0.08

243

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

112

0.98

0.00

1.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

342

0.99

0.00

3.5

2.9

—

(42870588) Differential panel, method unspecified - Blood

291

1.00

0.00

8.2

6.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

0.0

1.0

—

34.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

3.3

—

34.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.0

1.0

—

49.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

9.0

—

0.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

2.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.4

—

138.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.0

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.96

0.00

1.4

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3004451) EKG impression Narrative

0.00

0.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

9.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.0

2.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.96

0.00

15.0

9.6

24.2

24.3

mmol/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

1.8

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.93

0.00

1.1

1.5

—

(3022313) Gas panel - Capillary blood

1.02

0.00

5.0

2.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.95

0.00

1.7

1.9

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

5.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.86

0.00

2.8

0.9

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_EPIDIDYMIS and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_EPIDIDYMIS	0.951 [0.75, 1.2]	0.673
Birth year	0.985 [0.98, 0.99]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 637 males with CD2_BENIGN_EPIDIDYMIS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_EPIDIDYMIS.

N-year risk	Females	Males
1	No data	0.15%
5	No data	1.044%
10	No data	2.681%
15	No data	5.038%
20	No data	8.452%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_EPIDIDYMIS – Benign neoplasm: Epididymis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Epididymis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints